A detailed history of Redmile Group, LLC transactions in Silence Therapeutics PLC stock. As of the latest transaction made, Redmile Group, LLC holds 1,899,317 shares of SLN stock, worth $12.9 Million. This represents 2.26% of its overall portfolio holdings.

Number of Shares
1,899,317
Previous 2,014,296 5.71%
Holding current value
$12.9 Million
Previous $38.3 Million 9.73%
% of portfolio
2.26%
Previous 2.5%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$15.53 - $21.74 $1.79 Million - $2.5 Million
-114,979 Reduced 5.71%
1,899,317 $34.5 Million
Q2 2024

Aug 14, 2024

SELL
$18.31 - $23.91 $244,859 - $319,748
-13,373 Reduced 0.66%
2,014,296 $38.3 Million
Q1 2024

May 15, 2024

BUY
$17.39 - $26.25 $35.3 Million - $53.2 Million
2,027,669 New
2,027,669 $43.8 Million

Others Institutions Holding SLN

About Silence Therapeutics plc


  • Ticker SLN
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 35,888,400
  • Market Cap $243M
  • Description
  • Silence Therapeutics plc, a biotechnology company, focuses on the discovery and development of novel ribonucleic acid (RNA) therapeutics in hematology, cardiovascular, and other rare and metabolic indications. The company's platform includes mRNAi GalNAc Oligonucleotide Discovery platform designed to accurately target specific disease-associated...
More about SLN
Track This Portfolio

Track Redmile Group, LLC Portfolio

Follow Redmile Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Redmile Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Redmile Group, LLC with notifications on news.